S0820, Adenoma and Second Primary Prevention Trial
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2106377
下载链接
链接失效反馈官方服务：
资源简介：
The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal cancers in patients previously treated for Stages 0 through III colon or rectal cancer.
创建时间：
2013-03-15
